About this raise

Med-X, with a valuation of $43.2 million, is raising funds on PicMii. The company has developed many all-natural and plant-based brands that are replacing chemicals to solve everyday issues of people. The products are sold through major retail and healthcare distributors. The flagship product lines of Med-X include Nature-Cide and Thermal-Aid. Med-X has a high demand and is known for its all-natural solutions and reported 80% revenue growth in 2022. Dr. David Toomey and Matthew Mills founded Med-X in February 2014. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $3 million. The campaign proceeds will be used for acquisitions, marketing, working capital, hiring, product registrations, and research and development.

Expand

Investment Overview

Not Funded: $0

Deal Terms

Total Commitments ($USD)

Platform
PicMii
Start Date
01/23/2023
Close Date
05/23/2023
Min. Goal
$10,000
Max Goal
$3,000,000
Min. Investment

$500

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$0.25

Pre-Money Valuation

$43,211,544

Company & Team

Company

Year Founded
2014
Industry
Consumer Products, Goods & Services
Tech Sector
Cleantech
Distribution Model
B2B/B2C
Margin
Low
Capital Intensity
High
Location
Canoga Park, California
Business Type
Growth
Company Website
Visit Website

Team

Employees
10
Prior Founder Exits?
No
Founder Name
Jennifer Mills
Title
President
Founder Name
Matthew Mills
Title
CEO

Funding data not publicly available

Financials

as of Fiscal Year 2021
 Revenue -2.3% YoY
$1,033,750
 Monthly Burn
$408,953
 Runway
3.3 months
Gross Margin
13%

Summary Profit and Loss Statement

FY 2021 FY 2020

Revenue

$1,010,431

$1,033,750

COGS

$879,662

$870,539

Tax

$1,600

$1,600

 

 

Net Income

$-4,907,432

$-3,541,031

Summary Balance Sheet

FY 2021 FY 2020

Cash

$1,367,366

$752,823

Accounts Receivable

$28,616

$150,929

Total Assets

$3,816,184

$3,166,753

Short-Term Debt

$30,927

$398,263

Long-Term Debt

$29,032

$11,438

Total Liabilities

$59,959

$409,701

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Total Prior Capital Raised
$13,736,422
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
05/27/2025 DealMaker Securities $50,894,025 $1,022,943 Equity - Common Active RegCF
11/09/2023 Dalmore Group $102,217,405 $3,936,422 Equity - Common Funded RegA+
05/23/2023 PicMii $43,211,544 $0 Equity - Common Not Funded RegCF
09/10/2021 truCrowd $88,552,772 $15,595 Equity - Common Funded RegCF
06/27/2019 StartEngine - $7,000,471 Equity - Common Funded RegA+
Create a free account today to gain access to Kingscrowd analytics.

Growth Charts

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Med-X on PicMii 2023
Platform: PicMii
Security Type: Equity - Common
Valuation: $43,211,544
Price per Share: $0.25

Follow company

Follow Med-X on PicMii 2023

Buy Med-X's Deal Report

Warning: according to the close date for this deal, Med-X may no longer be accepting investments.

Med-X Deal Report

Get Kingscrowd's comprehensive report on Med-X including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Med-X is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Med-X deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge